BamSEC and AlphaSense Join Forces
Learn More

Cantabio Pharmaceuticals Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.4
from 8-K 3 pages Cantabio Pharmaceuticals Inc. Secured Convertible Debenture
12/34/56
EX-10.2
from 8-K 2 pages Amendment Agreement
12/34/56
EX-10.1
from 8-K 6 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K ~5 pages Form of Debt Conversion Agreement
12/34/56
EX-10.4
from 8-K 3 pages Cantabio Pharmaceuticals Inc. Secured Convertible Debenture
12/34/56
EX-10.3
from 8-K 2 pages Amendment Agreement
12/34/56
EX-10.2
from 8-K 13 pages Article 1. Definitions and Interpretations
12/34/56
EX-10.1
from 8-K 6 pages Securities Purchase Agreement
12/34/56
EX-10.11
from S-1 30 pages Dated Cambridge Enterprise Limited (“Ce”) (1) and Cantabio Pharmaceuticals Inc. (2) (“Licensee”) Data and Know-How Licence Agreement Case No: Tot-3254-16 Contents
12/34/56
EX-10.2
from S-1 4 pages Amended and Restated Securities Purchase Agreement
12/34/56
EX-10.4
from 8-K 3 pages Form of Debenture
12/34/56
EX-10.3
from 8-K 5 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 13 pages Security Agreement
12/34/56
EX-10.1
from 8-K 5 pages Securities Purchase Agreement
12/34/56
EX-10.5
from 10-K 14 pages Confidential Private Placement Subscription Agreement
12/34/56
EX-10.4
from 10-K 5 pages Agreement
12/34/56
EX-10.3
from 10-K 14 pages Trade Secret License Agreement
12/34/56
EX-10.12
from 8-K 5 pages Agreement
12/34/56
EX-10.11
from 8-K 6 pages Gardedam Therapeutics Inc. Safe (Simple Agreement for Future Equity) July 21st 2015
12/34/56
EX-10.10
from 8-K 3 pages Investment Agreement
12/34/56